86 related articles for article (PubMed ID: 397015)
1. [Effect of secretin intramuscularly injected on pancreatic polypeptide, insulin and glucagon in diabetic patients (author's transl)].
Toyota T; Koizumi K; Kai K; Umezu M; Miura M
Horumon To Rinsho; 1979; 27(12):1395-8. PubMed ID: 397015
[No Abstract] [Full Text] [Related]
2. Stimulatory effect of secretin on pancreatic polypeptide in diabetic patients.
Toyota T; Koizumi M; Kai Y; Miura M; Umetsu M; Suzuki S; Goto Y
Endocrinol Jpn; 1980 Apr; 27(2):145-7. PubMed ID: 6997022
[TBL] [Abstract][Full Text] [Related]
3. The effect of graded doses of secretin on serum trypsin, serum pancreatic amylase, serum insulin, plasma somatostatin, and plasma pancreatic polypeptide in man.
Florholmen J; Burhol PG; Jorde R; Waldum HL
Scand J Gastroenterol; 1984 Jan; 19(1):24-30. PubMed ID: 6200924
[TBL] [Abstract][Full Text] [Related]
4. Effects of endogenous and exogenous secretin on plasma pancreatic polypeptide concentrations in dogs.
Koizumi F; Ohkawa A; Kawamura T; Ishimori A; Sasaki I; Kameyama J
Diabetologia; 1986 Apr; 29(4):238-43. PubMed ID: 3519339
[TBL] [Abstract][Full Text] [Related]
5. [The effect of secretin on the exocrine and endocrine pancreas. Part 4: Plasma insulin, glucagon and secretin concentrations and pancreatic exocrine secretion in response to a bolus injection of synthetic secretin in the rat (author's transl)].
Sakamoto C; Otsuki M; Maeda M; Ohki A; Yuu H; Yamasaki T; Morita S; Terashi K; Baba S
Nihon Naibunpi Gakkai Zasshi; 1980 Mar; 56(3):199-207. PubMed ID: 6154603
[No Abstract] [Full Text] [Related]
6. The effect of treatment of type 2 (insulin independent) diabetes mellitus on plasma concentrations of pancreatic polypeptide and glucagon.
Berger D; Floyd JC; Pek SB
Diabetologia; 1981 Aug; 21(2):120-5. PubMed ID: 7021284
[TBL] [Abstract][Full Text] [Related]
7. Glucagon responses to secretion and CCK-PZ in diabetes and chronic pancreatitis.
Kalk WJ; Vinik AI; Jackson WP
Horm Metab Res; 1978 Nov; 10(6):562. PubMed ID: 744578
[No Abstract] [Full Text] [Related]
8. Insulin response to glucose, tolbutamide, secretin, and isoprenaline in maturity-onset diabetes mellitus.
Deckert T; Lauridsen UB; Madsen SN; Mogensen P
Dan Med Bull; 1972 Oct; 19(7):222-6. PubMed ID: 5079926
[No Abstract] [Full Text] [Related]
9. [Effect of duodenal acidification on plasma secretin and pancreatic polypeptide in man (author's transl)].
Häcki WH; Gyr K; Kayasseh L; Halter F
Z Gastroenterol; 1979 Nov; 17(11):749-52. PubMed ID: 524950
[TBL] [Abstract][Full Text] [Related]
10. Serum glucose, insulin, total, pancreatic and enteric glucagon in dogs before and after pancreatectomy, in patients with gastrectomy and pyloroplasty and in diabetic children. Effects of insulin and of secretin.
Matsuyama T; Hoffman WH; Breuer RI; Zuckerman L; Lawrence AM; Foa PP
Mater Med Pol; 1977; 9(2):124-9. PubMed ID: 895187
[No Abstract] [Full Text] [Related]
11. [Abnormal increase in pancreatic polypeptide in the secretin-provocation test: hypoglycemia-induced?].
Wirth HP; Eberle C; Gautschi K; Meyenberger C; Ammann R
Schweiz Med Wochenschr; 1995 Apr; 125(15):735-9. PubMed ID: 7740287
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic polypeptide response to secretin in obesity: effects of glucose intolerance.
Glaser B; Zoghlin G; Pienta K; Vinik AI
Horm Metab Res; 1988 May; 20(5):288-92. PubMed ID: 3042579
[TBL] [Abstract][Full Text] [Related]
13. [Insulinemic response to various stimuli in normal, obese, diabetic and acromegalic subjects].
Benedetti A
Folia Endocrinol; 1968 Feb; 21(1):65-79. PubMed ID: 5754875
[No Abstract] [Full Text] [Related]
14. Stimulation of human pancreatic polypeptide and gastrin by Boots and GIH secretin: in vitro and in vivo studies.
Meryn S; Bauman WA; Panzer S; Straus E
Int J Clin Pharmacol Ther Toxicol; 1987 Jan; 25(1):1-6. PubMed ID: 3557722
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of synthetic and natural secretin on pancreatic secretion and on secretin, insulin, and glucagon levels in man.
Beglinger C; Gyr K; Werth B; Keller U; Girard J
Dig Dis Sci; 1982 Mar; 27(3):231-3. PubMed ID: 7042249
[TBL] [Abstract][Full Text] [Related]
16. [Metabolic risks of salbutamol in diabetic patients. A study using somatostatin (author's transl)].
Schlienger JL; Compagnie MJ; Dellenbach P; Stephan F
Nouv Presse Med; 1980 Sep; 9(32):2247-51. PubMed ID: 6106923
[TBL] [Abstract][Full Text] [Related]
17. Insulin stimulation by secretin in diabetics. Effects of repeated and of varied doses.
Hindberg I; Enk B; Persson I
Horm Metab Res; 1970 May; 2(3):131-4. PubMed ID: 5535406
[No Abstract] [Full Text] [Related]
18. [Plasma glucagon and insulin profile in obese non-diabetic and non-insulin-dependent diabetic patients on a daily 800 calorie diet].
Balázsi I; Varsányi-Nagy M; Nagy K
Orv Hetil; 1986 Aug; 127(33):2009-13. PubMed ID: 3537903
[No Abstract] [Full Text] [Related]
19. [Pancreatic polypeptide release to graded dose of secretin and caerulein].
Kobari M; Miura M; Koizumi M; Toyoda T; Goto Y
Horumon To Rinsho; 1983 Jun; 31(6):495-8. PubMed ID: 6883763
[No Abstract] [Full Text] [Related]
20. Serum pancreatic polypeptide and glucagon immunoreactivity in fasting healthy and diabetic children.
Walczak M; Mrozikiewicz D; Dmochowski K; Rewers M; Cichy W
Mater Med Pol; 1989; 21(1):38-42. PubMed ID: 2699344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
